Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

被引：0
作者：
Michele Kohli
Donna Lawrence
Jennifer Haig
Andrea Anonychuk
Nadia Demarteau
机构：
[1] OptumInsight,
[2] Health Economics and Outcomes Research,undefined
[3] GlaxoSmithKline Biologicals,undefined
[4] Global Vaccines Development,undefined
来源：
BMC Public Health | / 12卷
关键词：
Human papillomavirus; Cervical cancer; Vaccine; Cost-effectiveness; Markov model; Canada;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 276 条
  • [91] Edmunds S(undefined)undefined undefined undefined undefined-undefined
  • [92] Aljunid A(undefined)undefined undefined undefined undefined-undefined
  • [93] Zafar S(undefined)undefined undefined undefined undefined-undefined
  • [94] Saperi M(undefined)undefined undefined undefined undefined-undefined
  • [95] Amrizal S(undefined)undefined undefined undefined undefined-undefined
  • [96] Capri R(undefined)undefined undefined undefined undefined-undefined
  • [97] Gasparini D(undefined)undefined undefined undefined undefined-undefined
  • [98] Panatto N(undefined)undefined undefined undefined undefined-undefined
  • [99] Demarteau N(undefined)undefined undefined undefined undefined-undefined
  • [100] Demarteau B(undefined)undefined undefined undefined undefined-undefined
567891011121314